German innovation consultancy bridging EU bioeconomy research and market through coaching, networking, and commercialization support for R&D consortia.
I.CON. INNOVATION GMBH is a German innovation consultancy based in Ostfildern that specializes in translating research and development results into commercial and policy-relevant outcomes. Their core work involves coaching research teams and organizations on market introduction strategies, connecting bioeconomy and manufacturing players across industry-research boundaries, and facilitating the uptake of scientific outputs into business practice. Rather than conducting R&D themselves, they provide the business intelligence, networking infrastructure, and professional guidance that research consortia typically lack on their own. In practice, they act as the market-facing bridge in multi-partner projects, ensuring scientific results do not stop at the lab door.
ProBIO (2015-2017) placed ICON in a funded participant role explicitly delivering professional support for the uptake of bioeconomy R&D results toward market, further research, and policy.
ProBIO keywords — coaching, business, use of results, competitiveness — describe ICON's contribution as hands-on guidance to help research teams pursue commercial pathways.
ProBIO keyword 'linking bioeconomy players' and 'networking' reflect a specific capability in building connections across the bioeconomy value chain.
MEMAN (2015-2018) involved ICON as a third party in a project on integral material and energy flow management in the metal mechanic manufacturing sector.
Both H2020 projects were initiated in 2015, which makes a meaningful chronological evolution analysis impossible — there is no early versus late period to compare. The MEMAN project (third-party role, no associated keywords in the data) suggests an advisory or facilitation function on the margins of a manufacturing efficiency project, while ProBIO generated the full keyword profile: bioeconomy, market introduction, coaching, networking, exchange. If there is a directional signal at all, it points away from manufacturing process work and toward bioeconomy commercialization support as their more developed and explicit offering.
The available evidence points toward bioeconomy commercialization and research-to-market coaching as ICON's sharpest capability, making them a natural fit for future consortia that need a dedicated partner for exploitation, dissemination, and market uptake — particularly in food, bio-based materials, or circular economy contexts.
ICON has never coordinated an H2020 project — their two participations were as third party and as a funded participant, both within larger consortia. Despite only two projects, they accumulated 30 unique partners across 9 countries, which means they joined large, multi-partner consortia rather than small bilateral efforts. This pattern is consistent with an organization that brings a specific, bounded contribution — market expertise, coaching, networking — without driving the scientific or technical agenda of the project.
Across two projects, ICON connected with 30 unique partners in 9 countries — a disproportionately wide network relative to their project count, explained by their participation in large multi-partner consortia. Their geographic reach is European, with no evidence of a narrower regional focus within Germany or any particular country cluster.
Most SMEs in EU research consortia are technical contributors — laboratories, engineering firms, pilot-plant operators. ICON occupies a different niche: they are the business-facing partner that helps the consortium turn scientific outputs into market-ready propositions. For a project coordinator building a consortium that needs to demonstrate exploitation and market impact — as required by Horizon funding rules — ICON brings exactly that capability. Their combination of bioeconomy domain knowledge and coaching methodology in a compact SME package makes them easier to integrate than a large consultancy.
